Articles

Poll

Podcasts

Slideshows

Videos

A multi-state cross-sectional analysis linked chronic kidney disease with increased COVID-19 hospitalizations, indicating more severe disease outcomes


CKD Among Top Chronic Conditions Linked to COVID-19 Hospitalization

Stay updated with the latest healthcare breakthroughs, including FDA news and phase 3 trial readouts, in this week's essential news roundup.

The HCPFive: Top News for Healthcare Providers from the Week of 12/14

A cross-sectional study compares renal transplantation with dialysis, highlighting an improved sleep quality in end-stage renal disease.


Renal Transplantation May Lower Sleep Disorder Risk Versus Dialysis

A cross-sectional study indicates a link between urinary levels of measured metals and metalloids and the stages of cardiovascular-kidney-metabolic syndrome.


Metal Exposure Levels May Explain Cardiovascular-Kidney-Metabolic Stages

A retrospective observational cohort study identifies an association between patients undergoing peritoneal dialysis and their physical activity level. 


Increased Physical Activity Linked to Reduced Mortality In Peritoneal Dialysis

A retrospective cohort study developed and validated a predictive model for IgA nephropathy, using routinely available variables. 


IgA Nephropathy Prediction Model Aids 5-Year Survival Estimation

A meta-epidemiologic study highlights barriers to inclusion of older adults undergoing maintenance dialysis in randomized controlled trials. 


Older Patients on Maintenance Dialysis Underrepresented in RCTs

A review of 32 years of global data on FSGS highlights increased prevalence, with a limitation of biopsy variation and regional practices.


Global Data Suggest Increased Prevalence of Focal Segmental Glomerulosclerosis

Bomback, MD, MPH answers HCPLive’s questions regarding phase 3 VALIANT results and pegcetacoplan’s therapeutic ability in C3G and IC-MPGN. 

Phase 3 VALIANT Results for Pegcetacoplan In C3G, IC-MPGN, With Andrew Bomback, MD

The Holly system is a first-of-its-kind implantable, continuous dialysis system designed to give patients freedom from the cycle of center-based dialysis.

FDA Grants Breakthrough Device Designation to Holly Implantable Dialysis System

C3 Glomerulopathy

The HCPLive C3 glomerulopathy page is a resource for medical news and expert insights on C3G. This page features expert-led coverage, articles, videos and research on the therapies and development of treatments in C3G, and more.

IgA Nephropathy

The HCPLive Berger disease page is a resource for medical news and expert insights on IgA nephropathy. This page features expert-led coverage, articles, videos and research on the therapies and development of treatments in Berger disease, and more.

Focal Segmental Glomerulosclerosis

The HCPLive focal segmental glomerulosclerosis page is a resource for medical news and expert insights on FSGS. This page features expert-led coverage, articles, videos and research on the therapies and development of treatments in FSGS, and more. 

Chronic Kidney Disease

The HCPLive nephrology page is a resource for medical news and expert insights on kidney disease. This page features expert-led coverage, articles, videos and research on the therapies and development of treatments in nephrology, and more.

Nephrology